NEW YORK | Biomarkers could cut down the numbers of failed clinical trials, if fully embraced by the medical community, states a new report by GBI Research.
A sold-out crowd of pharmacy owners and managers spent their precious day off attending the fourth installment of the popular Business 2.0 education days on December 2.